United States · 
Who invested in Effector Therapeutics?
Effector Therapeutics's investors include SR One, U.S. Venture Partners, Abingworth, Novartis Venture Fund and Novartis, and 12 more on record.
201320152017201920212023
$45MSeries A$39MSeries C$15MRound
United States · Funded startup
Who invested in Effector Therapeutics
Funding summaryUpdated 26 Oct 2026
$99Mraised across 3 rounds since 2013, from 3 sources
$45MSeries A$39MSeries C$15MRound
- Latest round
- Round, $15MJan 2024
- Biggest round
- $45MSeries A · May 2013
- Investors
- 17
The funding story
Each circle is a round, placed by date and sized by amount. The line above is the running total.
- First round
- Series A, $45M May 2013
- Biggest round
- $45M Series A · May 2013
- Usual gap between rounds
- 6.4 years the median of 2
The rounds
- Jan 2024
- Jul 2017Series C$39M8 new3 returning
U.S. Venture Partners
SR One
Novartis
Abingworth
The Column Group- BioMed
Altitude- Abbvie Biotech
- Astellas
- Pfizer Venture Investments/ Alexandria
- Sectoral Asset
Reported by FinSMEsSEC filing: $17M sold, first sale Jul 2017
- May 2013Series A$45M7 new
- U.S. Venture Partners
Novartis Venture Fund- SR One
Osage University Partners- Abingworth
Astellas Venture Management
Mission Bay Capital
Reported by fiercebiotech.comSEC filing: $17M sold, first sale May 2013
Founders and team
From the SEC filings it signed: 2 on the team.
- Alana D. McNultyExecutive Officeri
- Stephen T. WorlandExecutive Officer, Directori
On the board, as filediDavid D. MakiDenis W. PatrickJohn W. SmitherJonathan D. RootKenneth J. HaasLaurence T. LaskySimeon J. GeorgeStefan D. Larson
Who was in which round
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Everyone who backed them
BioMedGrowth equity1round
Abbvie Biotechno record of our own yet1round
Astellasno record of our own yet1round
Pfizer Venture Investments/ Alexandriano record of our own yet1round
Sectoral Assetno record of our own yet1round
Missing a round, or an investor who was in one? Tell us.
Quick answers about Effector Therapeutics
How much has Effector Therapeutics raised?
Effector Therapeutics has raised $99M across 3 rounds since 2013.
When did Effector Therapeutics last raise?
Effector Therapeutics's most recent round was an Undisclosed round of $15M in Jan 2024.
What was Effector Therapeutics's biggest round?
Effector Therapeutics's largest round on record is $45M (Series A), in May 2013.
Who backed Effector Therapeutics first?
Effector Therapeutics's first round on record, in May 2013, was backed by U.S. Venture Partners, Novartis Venture Fund and SR One and 4 others.
What stage is Effector Therapeutics at?
Effector Therapeutics's latest named round is an Undisclosed round, in Jan 2024.
Where is Effector Therapeutics based?
Effector Therapeutics is based in the United States.
Companies like Effector Therapeutics
In the same sector, and raised in the last eighteen months.
Find investors like these
Search every investor by what they have actually funded, then narrow to your stage and market. Free.